HCTI Faces Delisting Risk Amid Financial Struggles
By ATTN Desk · Editorial oversight: Sean Han
Healthcare Triangle Inc. (HCTI): Overview and Outlook
Introduction
Healthcare Triangle, Inc. (Nasdaq: HCTI) provides technology services and solutions to healthcare and life sciences organizations. Its offerings include digital transformation, cloud computing, data lifecycle management, interoperability, security and compliance, and clinical and business performance optimization.
Corporate Structure
- Founded: 2020
- Headquarters: Pleasanton, California
- Type: Privately held
- Industry: IT Services and IT Consulting
- Employees: 201–500 (per LinkedIn)
Developments and News
Nasdaq Notice (May 20, 2025)
On May 20, 2025, Healthcare Triangle received a notification from Nasdaq regarding potential delisting of its securities. The notice cited substantial dilution following a private placement of Series A and B warrants. The company must submit a compliance plan by May 30, 2025, and is evaluating trading on the OTCQB market if delisting occurs.
SEC Filings
- Form 8-K (May 23, 2025): Item 3.01 disclosed the issuance of Series A and B warrants.
- Form 8-K (May 30, 2025): Item 3.01 report filed; details on material events not detailed in the current overview.
Annual Report (10-K, March 31, 2025)
- Revenue (FY 2024): $11.7 million, representing a 65% decrease from $33.2 million in FY 2023
- Cost of revenue: $8.81 million, a 67% decrease
- Operating expenses: $7.64 million, down from $14.47 million
- Net loss: $5.97 million, compared to a net loss of $8.69 million in the prior year
- Accounts receivable: $1.1 million, down from $3.6 million
- Cash and equivalents: $20,000, down from $1.23 million
- Acquisition: Assets from SecureKloud Technologies valued at $7.44 million, paid in Series B convertible preferred stock
- Internal controls: A material weakness in internal controls over financial reporting reported
Quarterly Report (10-Q, May 20, 2025)
The Q1 2025 filing updates operating metrics and financial statements; full details are available on SEC EDGAR.
Financial and Strategic Analysis
| Metric | Value |
|---|---|
| Share price (2025-06-13) | $0.0217 |
| Daily change | –27.67% |
| Volume | 382,378,119 |
| 52-Week range | $0.0060–$1.9000 |
| Market cap | $12.25 million |
| Enterprise Value | $13.64 million |
| Price/Sales (TTM) | 0.02 |
| Price/Book (MRQ) | 10.73 |
| Revenue (TTM) | $11.29 million |
| Net income (TTM) | –$5.81 million |
| Profit margin | –51.43% |
| ROA (TTM) | –29.72% |
| ROE (TTM) | –143.99% |
| Total cash (MRQ) | $6.83 million |
| Debt/Equity (MRQ) | 9.04% |
| Levered free cash flow | –$3.87 million |
- Liquidity remains constrained despite $6.83 million in cash; debt is 9.04% of equity.
- Profitability metrics indicate negative performance; revenue has contracted year-over-year.
- Valuation multiples are low on a sales basis, high on a book basis; share price hovers near its 52-week low.
- The SecureKloud acquisition adds cloud and data platform services; warrant issuances have led to dilution concerns.
Market Position and Industry Context
Healthcare Triangle operates within the healthcare IT consulting sector, addressing digital transformation needs of providers, payors, hospitals, and life sciences firms. Regulatory requirements and interoperability standards continue to drive demand. The pending Nasdaq compliance and negative financial metrics may influence capital access and market visibility.
tl;dr
- On June 13, 2025, HCTI shares closed at $0.0217 (–27.67%) on a volume of 382 million.
- Nasdaq issued a delisting notice on May 20, 2025, over dilution from Series A and B warrants; compliance plan due May 30, 2025; OTCQB under evaluation.
- FY 2024 revenue was $11.7 million (65% decline), net loss was $5.97 million, cash on hand was $20,000 as of December 31, 2024.
- SecureKloud asset acquisition ($7.44 million) adds cloud and data platform capabilities.
- Near-term outlook hinges on Nasdaq compliance, capital access, and execution of strategic initiatives.